首页> 外文OA文献 >Letter by Uretsky Regarding Article, “Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial”

【2h】

Letter by Uretsky Regarding Article, “Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial”

机译：苏塞茨基州关于文章的信，“患者患者患者的结果，患有紫杉醇洗脱支架的经皮冠状动脉介入或冠状动脉旁路移植接枝治疗，在经皮冠状动脉介入与紫杉孢涎和心脏手术（语法）试验中的协同作用中的协同作用中”

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Barry F. Uretsky;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. [J] . Morice MC, Serruys PW, Kappetein AP, Circulation: An Official Journal of the American Heart Association . 2010,第24期

机译：TAXUS经皮冠状动脉介入治疗与心脏外科手术之间的协同作用试验中，使用紫杉醇洗脱支架经皮冠状动脉介入治疗或使用冠状动脉搭桥术治疗的左新发主要疾病患者的结局。
2. Letter by Al-Atassi et al Regarding Article, "Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial" [J] . Al-Atassi Talal, Rodriguez Maria Lorena, Ruel Marc Circulation: An Official Journal of the American Heart Association . 2015,第1期

机译：Al-Atassi等人关于“ 3血管或左主冠状动脉疾病患者的经药物洗脱支架经皮冠状动脉介入治疗与旁路手术的成本效益：经皮冠状动脉介入与TAXUS协同作用的最终结果”和心脏外科手术（SYNTAX）试验”
3. Five-Year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial [J] . MoriceM.-C., SerruysP.W., KappeteinA.P., Circulation: An Official Journal of the American Heart Association . 2014,第23期

机译：经皮冠状动脉介入治疗与紫杉类药物和心脏手术试验的协同作用，左主要疾病患者经皮冠状动脉介入治疗或冠状动脉搭桥术治疗的五年结局
4. 18-Month Outcome After Percutaneous Intervention in Post-Coronary Artery Bypass Graft Patients [C] . J. Garcia-Tejada, M. Velazquez, F. Hernandez, International Congress on Coronary Artery Disease . 2007

机译：在冠状动脉后旁路接枝患者中经皮干预后18个月的结果
5. Factors responsible for loss to follow up in a longitudinal study compaing coronary artery bypass surgery and percutaneous coronary intervention . [D] . Vera, Orlando, Jr. 2010

机译：因素损失的后续追踪研究比较冠状动脉搭桥手术和经皮冠状动脉介入治疗。
6. Predictive Ability of the SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery Score II for Long-term Mortality in Patients with Three-vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Treated with Second-generation Drug-eluting Stents [O] . Ji-Qiang He, Xian-Peng Yu, Cheng Peng, 2015

机译：经第二代药物洗脱支架治疗的经皮冠状动脉介入治疗的三支冠状动脉疾病三血管冠状动脉疾病患者经皮冠状动脉介入治疗TAXus与心脏手术评分II的长期死亡率协同作用的预测能力
7. Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial [O] . Marie-Claude Morice, Patrick W. Serruys, A. Pieter Kappetein, 2014

机译：用经皮冠状动脉干预或冠状动脉旁路嫁接治疗左主要疾病患者的五年成果在经皮冠状动脉介入与Raxus和心脏手术试验之间的协同作用中
8. Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease. Executive Summary. Effective Health Care Program Research Report No. 9 [R] . 2007

机译：经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗冠心病的疗效比较。执行摘要。有效的医疗保健计划研究报告第9号

著录项

相似文献

相关主题

期刊订阅